Madrigal Pharmaceuticals (MDGL)
(Delayed Data from NSDQ)
$193.33 USD
-1.05 (-0.54%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $192.63 -0.70 (-0.36%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Earnings News For MDGL
-
Madrigal Pharmaceuticals Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial Results
-
Madrigal: Q4 Earnings Snapshot
-
Madrigal Pharmaceuticals Provides Corporate Updates and Reports Third Quarter 2023 Financial Results
-
Madrigal: Q3 Earnings Snapshot
-
Madrigal: Q2 Earnings Snapshot
-
Madrigal Pharmaceuticals Provides Corporate Updates and Reports Second Quarter 2023 Financial Results
-
Madrigal: Q1 Earnings Snapshot
-
Madrigal Pharmaceuticals Provides Corporate Updates and Reports First Quarter 2023 Financial Results
-
Madrigal: Q4 Earnings Snapshot
-
Madrigal Pharmaceuticals Provides Corporate Updates and Reports 2022 Fourth Quarter and Full Year Financial Results
-
Madrigal: Q3 Earnings Snapshot
-
Madrigal Pharmaceuticals Provides an Overview of Upcoming Resmetirom Data Presentations and Reports 2022 Third Quarter Financial Results
-
Madrigal: Q2 Earnings Snapshot
-
Madrigal Pharmaceuticals Provides Clinical and Business Updates and Reports 2022 Second Quarter Financial Results
-
Madrigal (MDGL) Posts Narrower than Expected Loss in Q2
-
Madrigal (MDGL) Q1 Earnings: Disappointment in the Cards?
-
Madrigal (MDGL) Q4 Earnings: What's in Store for the Stock?
-
What's in Store for Madrigal (MDGL) This Earnings Season?